Intellia Therapeutics (NTLA) ROA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -20.7% | -31.2% | -37.0% | -43.6% | -49.0% | -52.0% | ||
| Changes by years, y/y, % | -1pp | -10pp | -6pp | -7pp | -5pp | +19.8% | |||
Intellia Therapeutics. ROA, %
Intellia Therapeutics. ROA, changes, pp
Intellia Therapeutics (NTLA) ROA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROA, % | ? | -53.3% | -53.4% | -48.2% | -49.0% | -52.0% | -52.0% | |
| Changes by years, y/y, % | -15pp | -11pp | -4pp | -5pp | +1pp | |||
| Changes by quarters, q/q, % | -10pp | 0pp | +5pp | -1pp | -3pp | |||